Моделирование стоимости фармацевтической компании в процессах слияния и поглощения на рынке
The article analyzes the special features of the pharmaceutical industry as an object of mergers and acquisitions. The motives of the consolidation transactions in the pharmaceutical market are analyzed. The hypotheses about the influence of individual factors on the cost of the acquired company are developed. Using the econometric analysis, the effect of the presence of patents and intangible assets of the target, as well as the accessories to the absorber to the top 20 pharmaceutical industry on the value of the transaction is tested. The final research model can be used for the rapid assessment of the value of a pharmaceutical company as a potential object of mergers and acquisitions on the market.